Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 20 most recent Form 4 transactions.
| Jun 2 | BMRN | Biomarin Pharmaceutical… | AGRANT | 7,490 | — | — | +19.2% | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 2,200 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 734 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,800 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 513 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,002 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 125 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 368 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 450 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 1,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 544 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 800 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | DTOISS◆ | 2,460 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | MRSN | Mersana Therapeutics, Inc. | UTENDR | 1,567 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 12, 2025 | MRSN | Mersana Therapeutics, Inc. | AGRANT◆ | 61,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 10, 2025 | MGX | Metagenomi Therapeutics,… | AGRANT◆ | 21,000 | — | — | — | Open the original filing on SEC.gov |
| May 20, 2025 | BMRN | Biomarin Pharmaceutical… | AGRANT | 6,650 | — | — | +20.6% | Open the original filing on SEC.gov |
| Apr 10, 2025 | MCRB | Seres Therapeutics, Inc. | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |